Werner syndrome is an autosomal recessive genetic instability and cancer predisposition syndrome with features of premature aging. Several lines of evidence have suggested that the Werner syndrome protein WRN plays a role in DNA replication and Sphase progression. In order to define the exact role of WRN in genomic replication we examined cell cycle kinetics during normal cell division and after methyl-methane-sulfonate (MMS) DNA damage or hydroxyurea (HU)-mediated replication arrest following acute depletion of WRN from human fibroblasts. Loss of WRN markedly extended the time cells needed to complete the cell cycle after either of these genotoxic treatments. Moreover, replication track analysis of individual, stretched DNA fibers showed that WRN depletion significantly reduced the speed at which replication forks elongated in vivo after MMS or HU treatment. These results establish the importance of WRN during genomic replication and indicate that WRN acts to facilitate fork progression after DNA damage or replication arrest. The data provide a mechanistic basis for a better understanding of WRN-mediated maintenance of genomic stability and for predicting the outcome of DNA-targeting chemotherapy in several adult cancers that silence WRN expression.
Introduction
Werner syndrome (WS) is an autosomal recessive human genetic instability disorder with features of cancer predisposition and premature aging. 1 It is caused by mutations in a member of a conserved family of the RecQ helicase genes, WRN (RECQL2). 2 Mutations in two other members of this protein family in humans also cause genetic instability and cancer predisposition syndromes. Loss of BLM results in Bloom syndrome, 3 and mutations in RECQL4 lead to Rothmund-Thomson syndrome with a risk of osteosarcoma. 4 RecQ helicases have been implicated in regulating genome stability, 5 however, the specific mechanisms and pathways in which the WRN protein functions remain to be elucidated. WRN has been shown to interact with proteins involved in DNA repair, replication, and telomere maintenance. 6, 7 WRN-deficient cells exhibit chromosomal translocations and deletions (ibid.) and these cells are hypersensitive to DNA crosslinkers (cis-platinum, mitomycin-C, or 8-methoxypsoralen + UV light 8, 9 ), and to camptothecin. [10] [11] [12] Our previous work has demonstrated that both spontaneous and damageinduced homologous recombination was reduced in WRN-deficient cells, and that the reduced clonal survival of these cells could be suppressed by expression of the RusA bacterial resolvase, or of a dominant-negative allele of RAD51, SMRAD51, which blocks the generation of recombinant DNA molecules. 13, 14 These data suggest that WRN may participate in homologous recombination repair, possibly at the stage of resolution of recombination intermediates.
A substantial body of evidence also links WRN to telomere maintenance, 6, 7, 15 and work by Crabbe et al, suggested a defect in the lagging strand DNA replication of telomeric ends in WRN-deficient cells. 16 Involvement of WRN in replication may extend beyond telomeres. WS patient-derived primary fibroblasts were reported to replicate slowly and have a prolonged S phase, 17, 18 and a more recent study suggested an elevated rate of spontaneous replication fork inactivation in these cells. 19 In response to camptothecin or hydroxyurea, WRN can colocalize with sites of DNA synthesis as marked by foci of BrdU incorporation or of the single stranded DNA binding protein, RPA. 20, 21 WRN can also colocalize with homologous recombination factor RAD51 and RAD51 paralogs, and with the ATR kinase. 22 WRN is phosphorylated by ATR, the key regulator of the response to disrupted replication fork progression, and/or a related ATM kinase, which responds to DNA breaks. 23 The characterization of WRN-deficient cells has been done mostly on patient-derived WRN -/-cells and nonisogenic WRN +/+ controls. Thus it has been hard to assess whether the observed phenotypes are a consequence of WRN absence or a result of adaptation and/or clonal selection of cells to the absence of WRN. In this study we set out to establish whether acute WRN depletion in human cells would result in an increased sensitivity to replication stress induced by DNA damage or replication fork arrest; and if so, to determine whether this would correlate with increased inactivation of replication forks. We found that WRN-depleted human fibroblasts have a marked delay in completing the cell cycle after treatment with methyl methane sulfonate (MMS) or hydroxyurea (HU), e.g., these cells spend more time in late S and/or G 2 phases of the cell cycle than controls. Moreover, by measuring the lengths and types of replication tracks in stretched DNA fibers, we found that WRN is required for replication fork elongation on both MMS-damaged DNA and during recovery from HU-mediated fork arrest. These data are the first demonstration, in isogenic human cells, that WRN facilitates global fork progression during recovery from replication stress.
Results
WRN depletion delays recovery from DNA damage during S-phase. In order to determine the role of WRN in recovery from replication stress we found it necessary to use cell populations maximally enriched for S phase cells. Average tissue culture cell populations are abundant in G 1 cells, which are not affected by HU and are differentially affected by camptothecin, cis-platinum and MMS. Also, many WRN -/-cell line cultures have an increased fraction of G 1 cells compared to WRN +/+ lines, 28 which can further dilute effects produced by replication stress in WRN-deficient cells.
In order to avoid these potential pitfalls, we used assays that focused on S phase cells (see experimental design in Fig. 1A) . First, we used synchronization to enrich cell populations for S phase fraction. Cell cultures were arrested in late G 1 (G 1 (I) in Fig. 1A ) by treatment with mimosine. Then mimosine was removed and the cells were incubated for 8-10 hrs. At this time, when the bulk of the population was in S phase, cells were pulse-treated with MMS, and followed through the time course of recovery.
To compare isogenic cell lines, we depleted WRN from human fibroblasts. We first used a previously characterized retroviral shRNA, WRNsi. 26, 28 In addition, we developed a new, lentivirus-expressed shRNA, WRN2-4. Typically, 80-90% of WRN protein was depleted (Suppl. Fig. 1A ), and this level was maintained throughout the experiment.
In the absence of DNA damage, WRN-depleted and mockdepleted SV40-transformed fibroblasts finished the cell cycle and returned to G 1 (G 1 (II)) with similar kinetics (Fig. 1B) . Treatment of cells with MMS during S phase induced cell cycle delays in both WRN-depleted and control cells (Fig. 1B) . For the first 10 hrs after MMS, cells traversed through S and G 2 phases (not shown). At later time points, cells began to accumulate in G 1 (II), with WRNdepleted cells markedly delayed compared to controls (Fig. 1B) . Addition of a mitosis inhibitor nocodazole to cells recovering from MMS confirmed that not only progression from G 2 /M to G 1 was delayed in WRN-deficient cells, but also the completion of S phase (not shown).
The same experiment was performed using a different shRNA (WRN2-4, Suppl. Fig. 1B ) and with the addition of BrdU labeling step prior to MMS treatment (see experimental design in Fig. 1A) . BrdU was present between 0 and 8-10 hrs after release from mimosine, thereby labeling every cell that entered S phase during this interval. This BrdU+ population was identified in FACS profiles by comparison with BrdU-controls (mimosine-arrested cells incubated with BrdU), and the cell cycle progression of this population was followed for about 20 hrs (see an example in Fig. 1C ). BrdU incorporation allowed distinguishing between BrdU-cells remaining in G 1 (I), and BrdU+ cells reaching G 1 (II) (an arrowhead in Fig. 1C, right) , as well as cells in first and second S phases. Once again, WRN-depleted SV40 fibroblasts were slower than controls in completing the cell cycle after MMS treatment in S phase (Suppl. Fig. 1B ). This effect of WRN depletion on recovery from MMS was even more pronounced in a different SV40 fibroblast line, GM639 (Fig. 1D ). For example, 13 hrs after MMS treatment, control cells were largely in G 1 (II), while WRN-depleted cells remained predominantly in the first G 2 (time point 24 hrs in Fig. 1D) . A large proportion of WRN-depleted population remained in the first G 2 , while the bulk of control cells traversed into the second S phase (time point 32 hrs in Fig. 1D ).
To rule out a possibility that the difference between WRN-deficient and wild type cells was induced by mimosine, we preformed experiments in an asynchronous population ( Fig. 2A and B) . WRN-depleted and control fibroblasts were pulse-labeled with BrdU for two hours. MMS was added during the second hour of BrdU labeling and then both the drug and the nucleotide analog were removed. Cell cycle distributions prior to (all cells) and during MMS treatment (BrdU+ only cells) in both types of cells were similar ( Fig. 2A) . However, by 19 hrs after MMS, the progression of WRNdepleted cells that were in S phase during MMS treatment lagged behind controls ( Fig. 2A and B) in the generation of BrdU+ G 1 cells. Addition of caffeine during recovery shortened the delay of cell division in both types of cells (Suppl. Fig. 1C ). Thus MMS-induced delays were at least in part mediated by the ATR/ATM-dependent checkpoint. As before, without MMS treatment, WRN-depleted cells were not slower than controls in their progression from S phase to the next G 1 (Suppl. Fig. 1C) .
Taken together, the data obtained with both synchronized and unsynchronized SV40 fibroblasts indicate that loss of WRN causes a marked extension of the checkpoint-dependent delay of cell division induced by MMS treatment during S phase. This extension arises from prolonged pausing of cells in late S and/or G 2 phases of the cell cycle.
WRN depletion impairs recovery from HU-mediated replication arrest. In order to determine if the defect in recovery from replication stress observed in WRN-depleted cells was MMS-specific or more general, we treated WRN-depleted cells with HU. The experimental scheme was as shown in Figure 1A , except that HU was added to BrdU-labeled cells instead of MMS (BrdU was not present during incubation with HU). After 8 hrs of HU arrest, we could detect an approximately 4-5 hr delay in the kinetics of progression of WRN-depleted cells out of S phase and into the next G 1 , compared to controls (not shown). This WRN-dependent delay became more prominent after 11-13 hrs of HU arrest in S phase ( Fig. 2C and D) . For example, 12 hrs after HU (and 34.5 hrs after the start of the experiment), some control cells entered G 1 (II) while WRN-depleted cells remained in G 2 (Fig. 2C, 34 .5 hr, also see graph in 2D) Thus, WRN loss impairs recovery from replication arrest induced by HU.
To address whether the transformed status of SV40 fibroblast lines affects the WRN-dependent phenotype, we repeated the HU-mediated arrest and recovery experiments in primary human fibroblasts. WRN-depleted primary fibroblast cultures (see Suppl. Fig. 1A for depletion data) had significantly fewer cells that entered S phase after mimosine synchronization (Fig. 3B, upper) . This phenotype is unlikely to be caused by mimosine treatment, since untreated WRN-depleted cultures also had fewer S phase cells (not shown). Also, previous work has described an accumulation of G 1 cells in WRN-depleted primary fibroblasts. 28, 31 Interestingly, WRNdepleted primary fibroblasts that entered the cell cycle after mimosine synchronization did so on the same schedule as controls (compare 9 hr in Fig. 3C ). However, the appearance of BrdU+ G 1 (II) cells that completed the cell cycle was delayed in WRN-depleted fibroblasts, with more cells staying in late S/G 2 ( Fig. 3A , 17 to 22.5 hr, also and D). This phenotype is consistent with the previous observations made with WRN -/-primary fibroblasts, 19 and suggests that WRN loss caused an extension of S/G 2 phases.
HU treatment during S phase delayed cell cycle progression of both mock-depleted and WRN-depleted primary fibroblasts ( Fig.  3B-D) . However, 11.5 hrs after release from HU block when 10% of control population reached the subsequent G 1 , WRN-depleted cells remained in late S and/or G 2 , and no G 1 (II) cells could be detected (Fig. 3C, 34 hr, also 3D). Thus, WRN depletion from both primary and SV40-transformed human fibroblasts impairs recovery from HU-mediated replication arrest. Taken together, the data obtained thus far suggest a general defect in recovery from replication stress caused by depletion of WRN.
WRN depletion affects fork progression on MMS-damaged DNA. The defect in recovery from replication stress in WRNdepleted cells could have at least two distinct causes. First, WRN may stabilize or restore active replication forks that are slowed or stalled due to DNA damage or nucleotide depletion. In this case, when WRN is depleted, the fraction or activity of forks that are able to elongate after replication stress should be reduced. Alternatively, WRN may be involved in the repair of DNA strand breaks that emerge after irreversible breakdown of replication forks. In this case, WRN depletion should not have impact on the fate of replication forks, but should reduce efficiency of DNA repair in S and G 2 phases.
In order to determine whether WRN affects fork activity, we looked at the behavior of DNA replication in living cells by using immunofluorescent detection of replication tracks in stretched DNA fibers. DNA was stretched on silanized glass with the aid of micro-fabricated capillary channels (see Materials and Methods). The experimental design is outlined in Figure 4A : mimosine synchronized, mid S-phase SV40-transformed fibroblasts were labeled for 40 min with CldU, treated with 0.02% MMS for 20 min, and then labeled for an additional 40 min with IdU (in a separate experiment, we established that virtually no replication can be detected by fiber track analysis if the label is added during incubation with this dose of MMS, not shown). Untreated controls were consecutively labeled with CldU and IdU. DNAs were isolated in agarose plugs and all treatments were conducted at temperatures at or below 37°C to minimize potential breakdown of thermolabile alkylated bases. 32 Replication was detected by staining with antibodies to IdU or CldU. Since MMS treatment has been shown to reduce the rate of progression of replication forks, 33, 34 we first focused on measuring the lengths of the IdU and CldU segments in double-labeled tracks (Fig. 4A , track type a), as well as the lengths of IdU and CldU single-labeled tracks (Fig. 4A , track types b and c). In addition, we determined the ratios of CldU to IdU segment lengths in doublelabeled tracks (reviewed in ref. 35 for an in-depth discussion of the approach).
In our experimental design ( Fig. 4A ), CldU and IdU track length distributions of untreated cells should be the same, while MMS treatment should shorten the lengths of tracks labeled with IdU (post-damage) but not with CldU (pre-damage, Fig. 4B ). In addition, CldU track lengths in untreated and MMS-treated DNAs should be similar. All these expectations were met: in untreated WRN-depleted and control fibroblasts, CldU and IdU track lengths were similar, and the ratios of CldU to IdU segment lengths of double-labeled tracks were distributed around 1 ( Fig. 5A and C) . This confirms the assumption that double-labeled tracks are in fact generated by single forks (Fig. 4A) . Also, single-labeled tracks were overall longer than segments of double-labeled tracks of the same color (Fig. 5A) . Again, this is consistent with the interpretation that a vast majority of double-labeled tracks is produced by single replication forks, while single-labeled tracks can be produced by two diverging (or converging) forks.
Treatment of control cells with MMS between CldU and IdU pulses resulted in shortening of IdU (post-damage) but not CldU (pre-damage) tracks, as seen both by track length distributions (Fig. 5B) and by a shift of a bulk of CldU/IdU ratios of doublelabeled tracks to values above 1.5 (Fig. 5C, +MMS) . This indicates a decrease in fork progression rates after MMS, consistent with previous reports. 33, 34 In WRN-depleted fibroblasts, this effect of MMS on fork rates was exacerbated. All IdU track lengths, whether by newly fired forks (single-labeled, Fig. 5B, top) , or by ongoing forks (double-labeled, Fig. 5B bottom) , were significantly shorter in WRN-depleted cells after MMS than in controls, whereas CldU track lengths were virtually identical. Moreover, WRN-depleted cells had more forks in which post-damage progression was severely depressed. For example, in WRN-depleted cells 16% of ongoing forks had post-damage segments that were 10 or more times shorter than their pre-damage segments, compared to only 6% in control cells (Fig. 5C , p < 0.01 by chi square test and D = 0.325, p << 0.001 by KS test; also see Table 1 ).
This prompted us to examine whether WRN-depleted cells also had a higher proportion of forks that failed to elongate after MMS damage. Results of experiments performed with the original (CldU, then IdU) and a reversed (IdU, then CldU) order of addition of labels, were averaged to derive a mean value for the recovery of ongoing, e.g., double-labeled, forks. The labeling order was varied in order to eliminate the risk of a potential bias in track type identification caused by antibody staining artifacts. The results consistently showed a more dramatic MMS-dependent reduction in the fraction of ongoing forks in WRN-depleted cells (Fig. 5D) .
Taken together, our data suggest that MMS damage resulted in more dramatic fork slowing in WRN-depleted cells, as compared with controls. This was evident both in ongoing forks and in forks originated after MMS treatment. Moreover, slowing of ongoing forks in WRN-depleted cells was accompanied by a higher degree of apparent fork inactivation.
WRN depletion impairs fork progression, though not fork reactivation, after HU arrest. Next, we asked whether forks stalled by HU were also inactivated more readily in cells lacking WRN. Synchronized, mid-S phase SV40 fibroblasts were pulse-labeled with the first halogenated nucleotide (CldU or IdU) for 40 minutes, and then HU was added to the media for 4 hrs (in the presence of the first label), prior to transfer to media containing the second label (respectively, IdU or CldU) and no HU (Fig. 6) . Untreated controls were sequentially labeled with two labels for the same periods of time. Forks arrested with HU are thought to remain functional, at least for a period of time, unless cells lack protein factors that preserve activity of arrested forks. 36, 37 Therefore, in order to determine whether WRN plays a role in stabilizing arrested forks, we first determined the percentages of double-and single-labeled tracks in WRN-depleted and control SV40 fibroblasts before and after HU arrest.
Treatment with HU for 4 hrs resulted in a decrease in recovery of ongoing forks, even though a substantial number of forks that were labeled prior to HU addition were still able to resume DNA synthesis and incorporate the second label (Fig. 6B) . Remarkably, WRNdepleted cells were not different from controls in their ability to preserve activity of HU-arrested forks. An average 1.6-fold reduction in recovered forks was observed in WRN-depleted cells compared to a 1.4-fold reduction in controls. We next asked if the forks that resumed elongation after HU-mediated arrest progressed slower in WRN-depleted cells than in controls. Track length analysis of the data from one of the experiments analyzed in Figure 6B , showed that this was the case. For example, 29% of the forks that resumed replication after HU in WRN-depleted cells, traveled less than a fifth of the distance they traveled before HU (Table 1) . By comparison, in control cells only 7.2% of forks that resumed after HU fell into this category.
We also exposed SV40 fibroblasts to a longer HU arrest (7 hr), and measured the lengths of double-labeled tracks (in this case, IdUBrdU, Fig. 6C and D) . The analysis confirmed that forks resuming replication after HU-mediated arrest covered on the average less distance in WRN-depleted cells than in controls. For example, overall length distributions of post-HU segments of double-labeled tracks were significantly shorter in WRN-depleted cells (Fig. 6C) . Also, the ratios of pre-to post-HU segments in double-labeled tracks were on average higher in WRN-depleted cells. As seen before (Table 1) , a greater proportion of forks in WRN-depleted cells had very short post-HU segments (less than a fifth of the length of their corresponding pre-HU segments; Fig. 6D , D = 0.436, p << 0.001 for the track segment ratio comparison between WRN-depleted and control cells by KS test; also see Table 1 ). In the absence of HU treatment, the majority of ongoing forks in both WRN-depleted and control cells progressed at a uniform rate (Fig. 6D) , though it should be noted that in WRN-depleted cells a slightly higher proportion of forks may have traveled with an irregular rate (D = 0.186, p = 0.02 for pre HU track comparison between WRN-depleted and control cells by KS test).
In summary, these data indicate that WRN facilitates fork progression after HU-induced replication arrest, which is similar to the case observed for MMS-induced stress. However, WRN does not appear to be required for stabilizing forks during HU arrest, since a similar proportion of forks are able to resume DNA synthesis after HU removal in WRN-depleted and control cells.
Discussion
Several biochemical, cellular and evolutionary lines of evidence have implicated WRN in DNA replication either prior to or after DNA damage (see Introduction and refs. therein). In order to address this issue directly, we examined the replication behavior of intact cycling cells and of single DNA molecules with and without WRN protein. Our findings indicate that acute WRN depletion from human fibroblasts leads to a prolonged delay in cell cycle progression after S-phase MMS damage or HU-mediated replication arrest. WRN-depleted cells spent more time in late S and/or G 2 than control cells subjected to the same level of replication stress. This phenotype of WRN depletion was detectable not only in SV40-transformed fibroblast cell lines but also in primary fibroblasts. In fact, WRN-depleted primary fibroblasts were more severely impaired than transformed fibroblasts, and exhibited delays of cell division even in the absence of any exogenous DNA damage or replication arrest, consistent with previous findings of prolonged S phase in primary fibroblasts derived from Werner syndrome (WS) patients. 19 While it is possible that this phenotype was elicited by a low level of genotoxic stress associated with culturing or handling (for instance, oxygen tension or BrdU incorporation), it is still consistent with the conclusion that WRN is required for a robust and resilient S phase. Overall, these observations suggest that WRN may act either directly at replication forks to ensure fork progression, or on newly replicated DNA to repair S-phase damage. Using DNA fiber track analyses, we found that WRN can directly affect replication forks. Our results suggest that a higher proportion of forks progressed extremely slowly after MMS damage in WRN-deficient fibroblasts compared to controls. In addition, a greater proportion of forks either did not continue DNA synthesis after MMS damage or may have synthesized tracks too short to be detected (less than 0.5 microns long). These findings are consistent with the conclusion that WRN can facilitate fork progression through MMS-damaged DNA.
When we examined recovery of replication forks from replication arrest mediated by HU, we found that forks stalled by HU can remain stable, but that this stability does not appear to require WRN. What depends on WRN is the progression of replication forks after HU. In WRN-depleted cells the fraction of forks that resumed replication after HU was similar to controls, but these forks generated shorter tracks. This suggests either that the speed of fork progression was diminished, or that more forks terminated shortly after resuming replication. A third conceivable mechanism, that in WRN-depleted cells forks took longer to reactivate, is less likely because it would have manifested in the reduced fraction of forks that resumed replication.
The observation that forks may progress less efficiently after HU may hint that perturbation of dNTP pools during HU arrest has a lasting effect beyond stalling and resumption, which influences the quality of replication. It is possible that post-HU DNA synthesis is associated with the generation of mismatches and/or single-stranded gaps, which may elicit a requirement for factors such as WRN.
We did not detect major differences in fork progression in untreated WRN-depleted versus control SV40 fibroblasts, although a close look at the track length profiles reveals that WRN-depleted cells had more double-labeled tracks in which the ratio of first to second label segment lengths fell in the tail of the ratio distribution (Figs. 5C and 6D, also Table 1 ). This difference may suggest a higher rate of spontaneous pausing or inactivation in a small subset of forks in the absence of WRN. A similar tendency was reported by Rodrigues-Lopez et al. based on single-label replication track analysis of primary fibroblasts from WS patients. 19 The authors detected differences in mean lengths of replication tracks between WRN +/+ and WRN -/-lines; these and other data were consistent with the conclusion that in WRN -/-cells a fraction of forks was pausing or inactivating prematurely. Arguably, the differences between WRN+ and WRN-cells observed by Rodriguez et al., may be more pronounced than the ones we report in this work. Our data (Figs. 2 and 3 ) lead us to think that this can be explained by the transformed status of SV40 fibroblasts (for example, inactivation of p53), which may make them less dependent on WRN. It is also conceivable that some phenotypes of WS cells may be modified by a history of propagation in the absence of WRN and are not recapitulated when WRN is depleted in wild type cells.
What mechanistic models could explain the role of WRN in replication fork progression after treatment with MMS or HU, the two agents with substantially different modes of action? Since WRN absence extends the caffeine-sensitive delay of the cell cycle after replication stress, it is more likely that in WRN-deficient cells the ATR-CHK1 and/or ATM-CHK2 checkpoint signaling is elevated and/or extended, and that WRN is a downstream target of one or both of these checkpoint pathways, rather than an upstream sensor.
Consistent with this, the fork progression defects in WRN-depleted cells could be explained by failure to bypass or eliminate the lesions common to MMS and HU.
MMS generates DNA base damage that can be repaired by at least three pathways: base excision repair (BER), 38 homologous recombination (HR) 39 or lesion bypass. 36, 40 Lesion bypass may occur by mutagenic translesion synthesis (TLS), or by a non-mutagenic pathway that involves HR-mediated template switching (ibid, 41 ). Loss of the key proteins in each of these pathways confers hypersensitivity to MMS. [42] [43] [44] [45] [46] BER and HR have also been implicated in the response to HU. Cells defective in the poly(ADP-ribose) polymerase PARP-1 are sensitive to HU and show a cell cycle progression delay after HU arrest. 47 HU treatment also induces RAD51 focus formation, 11, 48 and deficiency in the RAD51 paralogs XRCC2 49 and XRCC3, 50 or mutation of a CHK1 phosphorylation site in RAD51 51 render cells hypersensitive to HU. Finally, there is evidence of cross talk between HR and BER at HU-stalled forks. 47 Few data as yet implicate TLS or specialized polymerases in the recovery from HU arrest. 52, 53 However, the lesion bypass pathway in general, and TLS in particular, have been suggested to collaborate with HR. [54] [55] [56] Importantly, several findings now indicate that some of these repair proteins can influence fork progression rates. Overexpression of TLS polymerases can slow down the global rates of fork progression. 57 The key HR protein RAD51 and the RAD51 paralog XRCC3, appear to slow fork progression on DNA containing cis-Pt or BPDE adducts. 58, 59 WRN could plausibly participate in each of the above-mentioned pathways. For example, WRN plays a role in RAD51-dependent HR repair, 13, 14, 24 BER 60 and has been shown to interact physically or functionally with RAD52, 61 BRCA1, 62 TLS polymerases, 63 FEN-1, 64 PARP-1, 65 WRNIP/Mgs1 66 and PCNA. 67 Thus, one simple model that could explain why WRN-depleted cells exhibit impaired replication fork progression after genotoxic stress is that WRN facilitates the elimination of single-stranded gaps arising behind the fork due to a bypass of an MMS lesion or a replication restart after HU (Fig. 7) . In order to do that, WRN could participate in and/or cooperate with gap filling by TLS or by HR-mediated template switching, as well as with BER-mediated gap filling or lesion repair. 36 In each instance, the repair activity immediately behind the fork may affect fork progression rate.
A specific scenario can be envisioned, where WRN participates in the final stage of template switch-mediated gap filling by resolving a D-loop between daughter DNA strands (Fig. 7) . This is somewhat similar to the role proposed for the yeast RecQ helicase, Sgs1 68 and is consistent with the role of WRN in resolution of HR intermediates. 14 This also agrees with the argument that D-loops may slow 
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fork progression. 58 WRN could also promote BER specifically behind the fork but not ahead of it, which would eliminate the risk of forks running into BER intermediates-nicked and gapped DNA-and thus would improve fork progression. Recent work has shown that the human BLM RecQ helicase defective in Bloom syndrome is required for optimal fork velocity during unperturbed S phase 69 and for resumption of replication by HU-or aphidicolin-arrested forks. 70 Our results describe a complementary role for WRN-that of promoting progression of forks that resume replication-and thus begin to address the mechanistic basis of functional redundancy and cooperation among human RecQ helicases in maintaining genome integrity. It should be possible to further explore which pathways-HR, BER or lesion bypasscollaborate with WRN, BLM or other human RecQ helicases at replication forks by measuring fork progression rates in cells that lack individual RecQ helicases, alone or together with one or more of the interacting proteins described above.
The results reported here have implications for understanding the pathogenesis of Werner syndrome as well as the driving force behind silencing of WRN in a subset of human cancers. 71 It is accepted that WRN-deficient cells are genetically unstable and that this instability drives the development of clinical symptoms of the syndrome over a lifetime of an individual, or promotes tumor progression. Our data support the view that genomic instability of WRN -/-cells may result from a defect in the response of replication forks to DNA damage or arrest, whether due to endogenous insults such as reactive oxygen species, or to environmental genotoxins or chemotherapeutic agents. Figure 5D as the ratio of double-labeled tracks to all tracks containing the first label. Results of two experiments performed with CldU, then IdU or: IdU, then CldU order of labels in GM639cc1 fibroblasts were averaged. 250 to 650 tracks were collected and analyzed for each data point. Error bars are standard deviations. (C) WRN-depleted (WRN2-4) GM639cc1 fibroblasts show a HU-dependent shortening of replication tracks. An independent experiment performed as in (A), only with IdU as a first label, BrdU as a second label and HU arrest for 7 hrs. Length distributions in pre-HU (IdU) and post-HU (BrdU) segments of double-labeled tracks in cells released from HU arrest were plotted as in Figure  5B . (D) IdU/BrdU ratios determined for the experiment described in (C) were plotted as in Figure 5C . The P values shown in (C) and (D) were determined in chi square tests.
Materials and Methods
Cells and culture. Primary human dermal fibroblasts were obtained from Clonetix and used at passages 14-18. SV40-transformed GM639 and GM847 fibroblast cell lines were obtained from the Coriell Institute Cell Repositories (Camden NJ). GM639cc1 is a pNeoA-carrying derivative of GM639. 24 Drugs and dyes. Stock solutions of 5-bromodeoxyuridine (BrdU; 10 mM in water), 5-iododeoxyuridine (IdU, 2 mM in water), 5-chlorodeoxyuridine (CldU, 10 mM in water), caffeine (100 mM in DMSO), nocodazole (0.5 mg/ml in DMSO) and hydroxyurea (HU, 1 M in PBS) were stored at -20°C until use. MMS was diluted in PBS or water to 1-5% prior to use. Mimosine (10 mM in growth media) was stored at 4°C. Propidium iodide (10 mg/ml in PBS) was stored at 4°C and 4,6'-diamidino-2-phenylindole (DAPI, 1 mg/mL in water) was stored at -20°C. DAPI was obtained from Accurate Chemical and Scientific Corp (Westbury, NY), and the rest of the chemicals from Sigma (St. Louis, MO).
Cell growth, synchronization and drug treatments. All cell strains or lines were grown as adherent monolayers in Dulbecco Modified Minimal Essential Medium (DMEM) supplemented with 2 mM L-glutamine and 10% fetal bovine serum (Hyclone, Ogden, UT) in a humidified 5% CO 2 , 37°C incubator.
To synchronize cells, subconfluent cultures were treated with 0.5 mM mimosine for 12-14 hours. 25 Cells were then washed in PBS and incubated with fresh media for 8-10 hours. At this time, cells released from the block reached mid to late S phase, and were treated with HU or MMS for replication assays or cell cycle recovery experiments. HU was added at 2 mM, and MMS was added at 0.005% (0.55 mM) for 1 hr unless stated otherwise. BrdU and other halogenated nucleotides were added to cells to a final concentration of 50 μM, caffeine was used at 3 mM, and nocodazole at 50 ng/ml.
RNAi-mediated depletion of WRN. WRNsi is a hairpin with the stem sequence corresponding to positions 160 to 184 in the WRN ORF (accession # NM_000553; 1 is A in ATG). It was expressed from the pBABEpuro retroviral vector. 26 WRN2-4 is a hairpin with the stem sequence corresponding to WRN ORF positions 578 to 597. This hairpin was cloned into pLKO.1 lentiviral vector 27 between EcoRI and AgeI sites, under the control of the human U6 promoter. Virus was generated by transient transfection of 293T cells. Human fibroblasts were transduced with pBABEpuro-WRNsi, pLKO.1-WRN2-4, or the respective empty vectors, and placed on puromycin selection (1 μg/ml for primary fibroblasts and GM847 and 1.5 μg/ml for GM639) at 20 hours after infection.
Western blotting. Cells were harvested for Western blot analysis and cell cycle and replication assays at 5-7 days post infection. Western blotting of WRN was done as previously described, 24 with the rabbit α-WRN (Novus Cat. #NB100472A). For loading controls, α-Chk1 (Santa Cruz Cat. #sc-8408) antibody was used against CHK1 and α-GAPDH (Abcam Cat. # ab9482) was used against GAPDH. Proteins were visualized by ECL (Amersham) and quantified using the Storm Phosphorimager and ImageQuant software (Molecular Dynamics).
Staining for BrdU incorporation and FACS. DNA of ethanolfixed cells was denatured with 2 N HCl and 0.5% Triton X100, and neutralized in 100 mM Na borate pH8.5. Cells were next washed in IFA buffer (10 mM HEPES pH7.4, 150 mM NaCl, 5% normal goat serum, 0.1% Na azide) supplemented with 0.5% Tween 20. Cells were resuspended in IFA containing 10 μL of FITC-conjugated mouse α-BrdU antibody (Beston-Dickinson) per 10 6 cells and incubated on ice in the dark for 1 hr. Cells were washed again with IFA/Tween and resuspended for FACS analysis in PBS with 10 μg/mL propidium iodide and 100 μg/mL RNAse A. DAPI staining was performed as previously described. 28 Data analysis and presentation were done with Summit software (Dako, Carpinteria, CA), and cell cycle phase quantitations were done with Mcycle software (Phoenix Flow Systems, San Diego, CA). To quantify BrdU incorporation, the position of the BrdU-negative population was determined using flow cytometric profiles of relevant negative control samples with no incorporation. Cells with fluorescence above the negative control level were considered positive.
Microchannel fabrication, DNA fiber stretching and replication track analysis. PDMS microchannels were fabricated using standard photolithography and soft lithography procedures. 29 SU8-2 was spun on silicon wafers at 500 rpm for 10 sec. and 3000 rpm for additional 30 sec. The heights of microchannels were 3.25 μm as measured with a surface profilometer (KLA-Tencor, model P15, San Jose, CA). DNA stretching was performed as described, 30 with modifications. Glass cover slips were cleaned in nitric acid:hydrochloric acid 2:1, silanized with a solution of 12.6 μl N-trimethoxysilylpropyl-N,N,N-trimethylammonium chloride (Gelest, SIT8415.0) and 6 μl vinyltrimethoxysilane (Gelest, SIV9220.0) per 50 ml of water at 65°C for 17.5 hrs, and stored in ethanol at 4°C. DNAs from cells harvested by trypsinization were isolated in agarose plugs as described in manufacturer recommended protocols for the CHEF-DR II PFGE apparatus (Bio-Rad), with the exception that MMS-treated DNAs and their control counterparts were processed at tempera- Figure 7 . Putative roles of WRN in replication fork progression on MMSdamaged DNA or after HU-mediated replication arrest. Fork progression on MMS-damaged DNA may depend on lesion bypass by template switching, mediated by HR and/or by a TLS polymerase; the lesion is removed by BER. All three reactions may be facilitated by WRN. In one specific version of the model, WRN resolves a D-loop that arose from template switching. WRN may also coordinate BER with fork movement. Fork stalling in the presence of HU may lead to single-stranded gaps as the replicative helicase unwinds a stretch of DNA ahead of the replisome. Once the fork resumes elongation, these gaps may be eliminated by re-initiation of Okazaki fragments and at a stalled though otherwise intact 3' terminus of a leading strand. However, it is conceivable that these gaps may remain behind as the replisome reinitiates downstream. In this case, gaps may be filled by template switching mediated by HR and/or by TLS polymerases. Shown here is the template-switching scenario, where WRN plays a role similar to the one we show for a fork traversing MMS-damaged DNA.
tures at or below 37°C. To release DNA, plugs were briefly heated to 75°C and incubated with β-agarase (NEB). To stretch DNA, oxygen plasma-treated (to decrease hydrophobicity) PDMS matrices with series of microchannels 50-450 μm wide were laid over cover slips, and DNA was loaded into channel space by capillary tension. PDMS matrices were then removed and cover slips were treated with methanol:acetic acid 3:1 for 3 min and air dried. DNA was stained with YOYO-1 (Molecular Probes, 10 mM in TE with 20% β-mercaptoethanol) to inspect the quality of stretching. For immunostaining, cover slips were incubated in 2.5 N HCL for 40 min, neutralized in 0.1 M Na borate pH 8.0 and PBS, and blocked in PBS/5% BSA/0.5% Tween 20. The following antibodies were used, in that order: rat α-CldU/BrdU (Serotec, Cat.# MCA2060), goat α-rat Alexa 594-conjugated (Molecular Probes, Cat.# A11007), mouse α-IdU/BrdU (BD Biosciences, Cat.# 347580), and goat α-mouse Alexa 488-conjugated (Molecular Probes, Cat.# A11001). Antibody dilutions were made in PBS/5% BSA/0.5% Tween 20 with 10% normal goat serum and cover slips were also blocked in this buffer between α-rat secondary antibody and mouse α-IdU/BrdU antibody. Washes between antibodies were done in PBS/1%BSA/0.1% Tween 20. Cover slips were mounted in 10% PBS/90% glycerol/10 mM DTT.
Confocal microscopy of stretched DNAs was performed on the Zeiss Axiovert microscope with a 100x objective. Scanning for areas with optimal density of molecules was done with the filter set to the color corresponding to the first label, and then ten to twenty digital images per channel were generated by tracking along their lengths. Lengths of tracks were measured in digital images using the attached Zeiss AxioVision software. Chi square tests were applied to frequency distributions of lengths of tracks. The ratios of first label to second label segment lengths in double-labeled tracks were analyzed with two nonparametric tests: frequency distributions were subjected to chi square tests, and datasets of ratio values were also subjected to Kolmogorov-Smirnov (KS) test. This was done to eliminate the risk that variations between tail end values in the ratio distributions will disproportionately influence confidence.
